Balyasny Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Balyasny Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-30,000	Closed	-$4.09M	–	1869
2020 Q3	$4.09M	Buy	+30,000	New	+$3.19M	0.03%	666
2018 Q2	–	Sell	-40,000	Closed	-$1.95M	–	2308
2018 Q1	$1.95M	Buy	+40,000	New	+$2.08M	0.01%	1003

Balyasny Asset Management's MYOK Position: Q2 2020 in Review

Balyasny Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 12,843 shares — an estimated $602K sold.

Balyasny Asset Management first reported a position in MYOK in Q1 2019 and held it in 2 quarters. The position peaked at $829K in Q1 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

Balyasny Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Balyasny Asset Management sold 12,843 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $602K.
Balyasny Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
Balyasny Asset Management's MyoKardia, Inc. Common Stock position peaked at $829K in Q1 2019.
235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.